Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $407.7200 (2.73%) ($398.5001 - $408.6800) on Wed. Jan. 7, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.41% (three month average) | RSI | 57 | Latest Price | $407.7200(2.73%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -0.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(38%) XBI(37%) QQQ(31%) SPY(29%) | Factors Impacting REGN price | REGN will decline at least -1.205% in a week (0% probabilities). VIXM(-12%) TLT(-6%) SHY(-3%) UUP(-2%) TIP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.205% (StdDev 2.41%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
Resistance Level | $411.51 | 5 Day Moving Average | $407.5(0.05%) | 10 Day Moving Average | $406.83(0.22%) | 20 Day Moving Average | $411.51(-0.92%) | To recent high | -6.3% | To recent low | 24.3% | Market Cap | $43.23b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |